CCL28



CCL28

F1FF1Q2QQ2T3TT3S4SS4E5EE5A6AA6I7II7L8LL8P9PP9M10MM10A11AA11S12SS12S13SS13C14CC14C15CC15T16TT16E17EE17V18VV18S19SS19H20HH20H21HH21V22VV22S23SS23G24GG24R25RR25L26LL26L27LL27E28EE28R29RR29V30VV30S31SS31S32SS32C33CC33S34SS34I35II35Q36QQ36R37RR37A38AA38D39DD39G40GG40D41DD41C42CC42D43DD43L44LL44A45AA45A46AA46V47VV47... and 67 more residue(s)...... and 67 more residue(s)

SMILES None
InChIKey None
Sequence FQTSEAILPMASSCCTEVSHHVSGRLLERVSSCSIQRADGDCDLAAVILHVKRRRICISPHNRTLKQWMRASEVKKNGRENVCSGKKQPSRKDRKGHTTRKHRTRGTHRHEASR

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL28

F1FF1Q2QQ2T3TT3S4SS4E5EE5A6AA6I7II7L8LL8P9PP9M10MM10A11AA11S12SS12S13SS13C14CC14C15CC15T16TT16E17EE17V18VV18S19SS19H20HH20H21HH21V22VV22S23SS23G24GG24R25RR25L26LL26L27LL27E28EE28R29RR29V30VV30S31SS31S32SS32C33CC33S34SS34I35II35Q36QQ36R37RR37A38AA38D39DD39G40GG40D41DD41C42CC42D43DD43L44LL44A45AA45A46AA46V47VV47... and 67 more residue(s)...... and 67 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.